ArticleProceedings of the National Academy of Sciences of the United States of America2014

Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.

Heinz Läubli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.